This signature was set up on fresh tumor tissue, which is often not available in retrospective series, but we have previously shown that the neoangiogenic transcriptomic signature is equivalent to the immunohistochemical expression of angiopoietin-2 (ANGPT2) in HCC tissue (15). Here, ANGPT2 is linked to neoplasm.